为规范我国双相障碍诊疗的临床治疗决策,全面提升双相障碍患者规范化诊断与治疗水平,中华医学会精神医学分会发起制定《中国双相障碍防治指南》(2025年版)(以下简称指南)。本计划书概要介绍该指南制定的背景和目的、制定方法、工作组成员及分工、指南注册、利益冲突、临床问题收集与遴选、指南依据的循证证据、撰写与外审、发布和传播等。
To standardize clinical treatment decisions and improve the comprehensive diagnosis and treatment of bipolar disorder in China, the Psychiatric Branch of the Chinese Medical Association initiated the Guidelines for the Prevention and Treatment of Bipolar disorder in China (2025 edition). This protocol summary describes the background and purpose of the guideline, the formulation method, working group members, division of responsibilities, guideline registration, conflicts of interest, collection and selection of clinical issues, the evidence-based foundation of the guideline, writing and external review, as well as publishing, dissemination, and other aspects.
方贻儒,洪武,刘铁榜,等. 《中国双相障碍防治指南》(2025年版)计划书[J]. 中华精神科杂志,2023,56(06):413-417.
DOI:10.3760/cma.j.cn113661-20230919-00077版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。